← Back to Search

Treatment for Sarcoidosis

N/A
Waitlist Available
Led By Mehdi Mirsaeidi, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 years
Awards & highlights

Summary

The purpose of this study is to develop a clinical dataset of sarcoidosis patients with a diagnosis of cancer who are categorized by date of birth, sex, race/ethnicity, clinical information, laboratory and imaging information, time of sarcoidosis onset, cancer type and treatment, time of cancer diagnosis, stage and grade.

Eligible Conditions
  • Sarcoidosis
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pathology Proven Sarcoidosis In Patients with Cancer
Secondary outcome measures
Cancer Cytogenetics and Sarcoidosis
Treatment Requirement of Sarcoidosis

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
935 Previous Clinical Trials
422,046 Total Patients Enrolled
Mehdi Mirsaeidi, MD5.03 ReviewsPrincipal Investigator - University of Miami
University of Miami
5Patient Review
The doctor was very attentive, answered all my questions and spent time getting to know me.
~28 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top